MELODY LEWIS: Open Payments
NPI 1427282854 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 52 payments from 8 companies in 2025. Trend: 2023 $196 · 2024 $804 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $219 |
| Phathom Pharmaceuticals, Inc. | 23 | $161 |
| Intercept Pharmaceuticals, Inc. | 5 | $80 |
| Ipsen Biopharmaceuticals, Inc | 3 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Ardelyx, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: VOQUEZNA, ENTYVIO, EOHILIA, OCALIVA, IQIRVO, IBSRELA, DUPIXENT, ZENPEP.
Industry payments across MS — which companies pay providers there.
